CHAPTER 90 Fever of Undetermined Origin
The term fever refers to a syndrome of malaise or nonspecific systemic clinical signs and pyrexia or hyperthermia. In this chapter, however, the terms fever and pyrexia are used interchangeably. Fever constitutes a protective physiologic response to both infectious and noninfectious causes of inflammation that enhances the host’s ability to eliminate a noxious agent.
A variety of stimuli—including bacteria, endotoxins, viruses, immune complexes, activated complement, and necrotic tissue—trigger the release of endogenous pyrogens by the phagocytic system, mainly the mononuclear cells, or macrophages. These endogenous pyrogens include interleukin-1, tumor necrosis factor, and interleukin-6, among others. They activate the preoptic nucleus of the hypothalamus, raising the set point of the thermostat by generating heat through muscle contraction and shivering and conserving heat through vasoconstriction.
In human beings several patterns of fever have been associated with specific disorders; however, this does not appear to be the case in dogs and cats. In people with continuous fever, the pyrexia is maintained for several days or weeks. This type of fever is associated with bacterial endocarditis, central nervous system lesions, tuberculosis, and some malignancies. In people with intermittent fever, the body temperature decreases to normal but rises again for periods of 1 to 2 days; this is seen in brucellosis and some malignancies. In remittent fever the temperature varies markedly each day but is always above normal (39.2° C); this type of fever is associated with bacterial infections. The term relapsing fever is used to refer to febrile periods that alternate with variable periods of normal body temperature, as seen in human beings with malaria.
The term fever of undetermined (or unknown) origin (FUO) is used liberally in veterinary medicine to refer to a febrile syndrome for which a diagnosis is not evident. In human medicine, FUO refers to a febrile syndrome of more than 3 weeks’ duration that remains undiagnosed after 1 week of thorough in-hospital evaluation. If the term FUO were to be used in the same way in animals as is recommended in human beings, few dogs and cats would actually have it. Therefore in this chapter the discussion focuses on the approach to a dog or cat with fever that does not respond to antibacterial antibiotic treatment and for which a diagnosis is not obvious after a minimal workup has been performed (e.g., complete blood count [CBC], serum biochemistry profile, urinalysis).
As a general rule, the clinician typically presumes that a dog or cat with fever has an infection until proved otherwise. This appears to be true in reality, as shown by the fact that a large proportion of dogs and cats with fever respond to nonspecific antibacterial treatment. No clinicopathologic evaluation is performed in most of these animals because the fever responds promptly to treatment.
In human beings, certain infectious, neoplastic, and immune-mediated disorders are commonly associated with FUO. Approximately one third of patients have infectious diseases; one third have cancer (mainly hematologic malignancies, such as lymphoma and leukemia); and the remaining third have immune-mediated, granulomatous, or miscellaneous disorders. In 10% to 15% of the patients with FUO, the underlying disorder remains undiagnosed despite intensive efforts. However, most of the review articles describing dogs and cats with FUO that have appeared in the literature extrapolate data from human papers.
On the basis of observations made in dogs and cats evaluated at our clinic and case reports in the literature, the most common cause of FUO appears to be infectious diseases, followed by immune-mediated, neoplastic disorders and miscellaneous (Table 90-1). However, despite aggressive evaluation, the cause of the fever cannot be determined in approximately 10% to 15% of small animals.
TABLE 90-1 Causes of FUO in Dogs and Cats
CAUSE | SPECIES AFFECTED |
---|---|
Infectious Bacterial | |
Subacute bacterial endocarditis | D |
Brucellosis | D |
Tuberculosis | D, C |
Mycoplasmosis | D, C |
Plague | C |
Lyme disease | D |
Bartonellosis | D, C |
Suppurative infection (abscesses [liver, pancreas], stump pyometra, prostatitis, discospondylitis, pyelonephritis, peritonitis, pyothorax, septic arthritis) | D, C |
Rickettsial | |
Ehrlichiosis, anaplasmosis, Rocky Mountain spotted fever, salmon poisoning | D, C |
Mycotic | |
Histoplasmosis | D, C |
Blastomycosis | D, C |
Coccidioidomycosis | D |
Viral | |
Feline infectious peritonitis | C |
Feline leukemia virus infection | C |
Feline immunodeficiency virus infection | C |
Protozoal | |
Babesiosis | D |
Hepatozoonosis | D |
Cytauxzoonosis | C |
Chagas’ disease | D |
Leishmaniasis | D |
Immune Mediated | |
Polyarthritis | D, C |
Vasculitis | D |
Meningitis | D |
Systemic lupus erythematosus | D, C |
Immune hemolytic anemia | D, C |
Steroid-responsive fever | D |
Steroid-responsive neutropenia | D, C |
Neoplastic | |
Acute leukemia | D, C |
Chronic leukemia | D, C |
Lymphoma | D, C |
Malignant histiocytosis | D |
Multiple myeloma | D, C |
Necrotic solid tumors | D, C |
Miscellaneous | |
Metabolic bone disorders | D |
Drug induced (tetracycline, penicillins, sulfa) | C, D |
Tissue necrosis | D, C |
Hyperthyroidism | C, D |
Idiopathic | D, C |
FUO, Fever of undetermined origin; D, dog; C, cat.
A dog or cat with FUO should be evaluated in a systematic fashion. In general, a three-stage approach is used at our clinic (Box 90-1). The first stage consists of a thorough history-taking and physical examination as well as a minimal database. The second stage consists of additional noninvasive and invasive diagnostic tests. The third stage consists of a therapeutic trial, which is instituted if no diagnosis can be obtained after completion of the second stage.
BOX 90-1 Diagnostic Evaluation of the Dog or Cat with FUO
FUO, Fever of undetermined origin; CBC, complete blood count; FNA, fine-needle aspiration; PCR, polymerase chain reaction.
Serum biochemistry profile and thyroxine concentration
Thoracic and abdominal imaging
Serial bacterial blood cultures
Immune tests (antinuclear antibody, rheumatoid factor)
Serologic tests or PCR (see Table 90-1)
Arthrocentesis (cytologic studies and culture)
Biopsy of any lesion or enlarged organ
Bone marrow aspiration (for cytologic studies and bacterial/fungal culture)
When a febrile patient does not respond to antibacterial treatment, a course of action must be formulated. A thorough history should be obtained and a complete physical examination performed. The history rarely provides clues to the cause of the fever. However, a history of ticks may indicate a rickettsial or hemoparasitic disorder, previous administration of tetracycline (mainly to cats) may indicate a drug-induced fever, and travel to areas where systemic mycoses are endemic should prompt further investigation consisting of cytologic or serologic studies or fungal cultures.
During a physical examination the lymphoreticular organs should be evaluated because numerous infectious diseases affecting these organs (e.g., ehrlichiosis, Rocky Mountain spotted fever, bartonellosis, leukemia, systemic mycoses) may cause fever. An enlarged lymph node or spleen should be evaluated cytologically by using specimens obtained by fine-needle aspiration (FNA). An FNA sample can also be obtained for bacterial and fungal culture and susceptibility testing if the cytologic studies reveal evidence of infection or inflammation. Any palpable mass or swelling should also be evaluated by using specimens obtained by FNA to rule out granulomatous, pyogranulomatous, and suppurative inflammation as well as neoplasia (see Chapter 75).
The clinician should thoroughly inspect and palpate the oropharynx, searching for signs of pharyngitis, stomatitis, or tooth root abscesses. The bones should also be thoroughly palpated, particularly in young dogs, because metabolic bone disorders such as hypertrophic osteodystrophy can cause fever associated with bone pain. Palpation and passive motion of all joints is also indicated in search of monoarthritis, oligoarthritis, or polyarthritis. A neurologic examination should be conducted to detect signs of meningitis or other central nervous system lesions. In older cats the ventral cervical region should be palpated to detect thyroid enlargement or nodules.
The thorax should be auscultated carefully in search of a murmur, which could indicate bacterial endocarditis. A thorough ocular examination may reveal changes suggestive of a specific cause (e.g., chorioretinitis in cats with feline infectious peritonitis or in dogs with monocytic ehrlichiosis).
A minimum database consisting of a CBC, serum biochemistry profile, urinalysis, and urine bacterial culture and susceptibility testing should always be carried out in dogs and cats with persistent fever. The CBC may provide important clues regarding the cause of the fever (Table 90-2). A serum biochemistry profile rarely yields diagnostic information in dogs and cats with FUO, although it can provide indirect information on parenchymal organ function. However, the finding of hyperglobulinemia and hypoalbuminemia may indicate an infectious, immune-mediated, or neoplastic disorder (see Chapter 89). The finding of pyuria or white blood cell casts in a urinalysis may indicate a urinary tract infection, which may be the cause of the FUO (i.e., pyelonephritis). Proteinuria associated with an inactive urine sediment should prompt the clinician to evaluate a urine protein/creatinine ratio to rule out glomerulonephritis or amyloidosis as the cause of the fever.
TABLE 90-2 Hematologic Changes in Dogs and Cats with FUO
HEMATOLOGIC CHANGE | COMPATIBLE WITH |
---|---|
Regenerative anemia | Immune-mediated diseases, hemoparasites, drugs |
Nonregenerative anemia | Infection, immune-mediated diseases, tissue necrosis, malignancy, endocarditis |
Neutrophilia with left shift | Infection, immune-mediated diseases, tissue necrosis, malignancy, endocarditis |
Neutropenia | Leukemia, immune-mediated diseases, pyogenic infection, bone marrow infiltrative disease, drugs |
Monocytosis | Infection, immune-mediated diseases, tissue necrosis, lymphoma, endocarditis, histiocytosis |
Lymphocytosis | Ehrlichiosis, anaplasmosis, Chagas’ disease, leishmaniasis, chronic lymphocytic leukemia |
Eosinophilia | Hypereosinophilic syndrome, eosinophilic inflammation, lymphoma |
Thrombocytopenia | Rickettsiae, leukemia, lymphoma, drugs, immune-mediated diseases |
Thrombocytosis | Infections (chronic), immune-mediated diseases |
FUO, Fever of undetermined origin.
Other diagnostic tests that may be called for in patients with FUO are listed in Box 90-1. Echocardiography is indicated only if the patient has a heart murmur because it rarely detects a valvular lesion in dogs without murmurs. Some of the infectious diseases listed in Table 90-1 can be diagnosed on the basis of serologic findings or polymerase chain reaction testing.
Fluid from several joints should be aspirated for cytologic evaluation and possibly bacterial culture because polyarthritis may be the only manifestation of a widespread immune-mediated disorder. Thoracic radiography and abdominal ultrasonography should be performed to search for a silent septic focus. In dogs and cats with neurologic signs associated with fever, a cerebrospinal fluid tap should be performed; in dogs, immune-mediated vasculitis or meningitis can cause marked temperature elevations. If a diagnosis has still not been reached, bone marrow aspirates for cytologic studies and bacterial and fungal culture should also be obtained. A leukocyte or ciprofloxacin scan may reveal a hidden septic focus. Finally, if a definitive diagnosis is ultimately not obtained, a therapeutic trial of specific antibacterial or antifungal agents or immunosuppressive doses of corticosteroids can be initiated.
If a definitive diagnosis is obtained, a specific treatment should be initiated.
The problem arises if the clinician cannot arrive at a definitive diagnosis. In these patients, changes in the CBC usually are the only clinicopathologic abnormality (see Table 90-2). That is, results of bacterial and fungal cultures, serologic tests, PCR, imaging studies, and FNAs are negative or normal. If the patient has already been treated with a broad-spectrum bactericidal antibiotic, a therapeutic trial of immunosuppressive doses of corticosteroids is warranted. However, before instituting immunosuppressive treatment, the owners should be informed of the potential consequences of this approach: primarily that a dog or cat with an undiagnosed infectious disease may die as a result of systemic dissemination of the organism after the start of treatment. Dogs and cats undergoing a therapeutic trial of corticosteroids should be kept in the hospital and monitored frequently for worsening of clinical signs, in which case steroid therapy should be discontinued. In patients with immune-mediated (or steroid-responsive) FUO, the pyrexia and clinical signs usually resolve within 24 to 48 hours of the start of treatment.
If no response to corticosteroids is observed, two courses of action remain. In one, the patient can be released and given antipyretic drugs, such as aspirin (10 to 25mg/kg PO q12h in dogs and 10mg/kg PO q72h in cats) or other nonsteroidal antiinflammatories, and then returned to the clinic for a complete reevaluation in 1 to 2 weeks. Antipyretics should be used with caution, however, because fever is a protective mechanism and lowering the body temperature may be detrimental in an animal with an infectious disease. Moreover, drugs such as dipyrone and flunixin can result in marked hypothermia, which may have adverse effects. Also of note is that some nonsteroidal antiinflammatory drugs have ulcerogenic effects, can cause cytopenias, and may result in tubular nephropathy if the patient becomes dehydrated or receives other nephrotoxic drugs. The second course of action is to continue the trial of antibiotics by using a combination of bactericidal drugs (e.g., ampicillin and enrofloxacin) for a minimum of 5 to 7 days.
Battersby IA, et al. Retrospective study of fever in dogs: laboratory testing, diagnoses and influence of prior treatment. J Small Anim Pract. 2006;47:370.
Bohnhorst JO, et al. Immune-mediated fever in the dog. Occurrence of antinuclear antibodies, rheumatoid factor, tumor necrosis factor and interleukin-6 in serum. Acta Vet Scand. 2002;43:165.
Dunn KJ, Dunn JK. Diagnostic investigations in 101 dogs with pyrexia of unknown origin. J Small Anim Pract. 1998;39:574.
Feldman BF. Fever of undetermined origin. Compend Contin Educ. 1980;2:970.
Henson KL, et al. Diagnosis of disseminated adenocarcinoma by bone marrow aspiration in a dog with leukoerythroblastosis and fever of unknown origin. Vet Clin Pathol. 1998;27:80.
Scott-Moncrieff JC, et al. Systemic necrotizing vasculitis in nine young beagles. J Am Vet Med Assoc. 1992;201:1553.
Ward A. Fever of unknown origin in cats and dogs. Vet Med. 1985;81:40.